Why Tessera Believes Its Gene Writing Platform Can Go Way Beyond CRISPR
Interview: Bio-Entrepreneur On The Hunt For The Definitive Genetic Medicine Platform
As the first CRISPR-based therapies draw closer to approval, the Flagship-backed biotech believes its gene writing tech is the ‘definitive’ genetic medicine platform.
